These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 24252386)

  • 21. Molecular basis of late-life globoid cell leukodystrophy.
    De Gasperi R; Gama Sosa MA; Sartorato E; Battistini S; Raghavan S; Kolodny EH
    Hum Mutat; 1999; 14(3):256-62. PubMed ID: 10477434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into Krabbe disease from structures of galactocerebrosidase.
    Deane JE; Graham SC; Kim NN; Stein PE; McNair R; Cachón-González MB; Cox TM; Read RJ
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15169-73. PubMed ID: 21876145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel homozygous GALC mutation: very early onset and rapidly progressive Krabbe disease.
    Kardas F; Uzak AS; Hossain MA; Sakai N; Canpolat M; Yıkılmaz A
    Gene; 2013 Mar; 517(1):125-7. PubMed ID: 23276707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
    Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
    Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare Saposin A deficiency: Novel variant and psychosine analysis.
    Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
    Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unfolded protein response is activated in Krabbe disease in a manner dependent on the mutation type.
    Irahara-Miyana K; Otomo T; Kondo H; Hossain MA; Ozono K; Sakai N
    J Hum Genet; 2018 Jun; 63(6):699-706. PubMed ID: 29615819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in GALC cause late-onset Krabbe disease with predominant cerebellar ataxia.
    Shao YH; Choquet K; La Piana R; Tétreault M; Dicaire MJ; ; Boycott KM; Majewski J; Brais B
    Neurogenetics; 2016 Apr; 17(2):137-41. PubMed ID: 26915362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splicing mutations of GALC in adult patient with adult-onset Krabbe disease: case report and review of literature.
    Su Y; Wei L; Wang L; Xu P; Mo M
    Neurocase; 2024 Apr; 30(2):63-67. PubMed ID: 38762762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
    Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
    J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale study of clinical and biochemical characteristics of Chinese patients diagnosed with Krabbe disease.
    Zhao S; Zhan X; Wang Y; Ye J; Han L; Qiu W; Gao X; Gu X; Zhang H
    Clin Genet; 2018 Feb; 93(2):248-254. PubMed ID: 28598007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel compound heterozygous mutation in GALC associated with adult-onset Krabbe disease: case report and literature review.
    Iacono S; Del Giudice E; Leon A; La Bella V; Spataro R
    Neurogenetics; 2022 Apr; 23(2):157-165. PubMed ID: 35013804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Krabbe disease: are certain mutations disease-causing only when specific polymorphisms are present or when inherited in trans with specific second mutations?
    Wenger DA; Luzi P; Rafi MA
    Mol Genet Metab; 2014 Mar; 111(3):307-308. PubMed ID: 24388568
    [No Abstract]   [Full Text] [Related]  

  • 34. An autopsy case report of adult-onset Krabbe disease: Comparison with an infantile-onset case.
    Sasaki M; Ebata M; Tanei ZI; Oda Y; Hamauchi A; Tanikawa S; Sugino H; Ishida Y; Abe T; Arai N; Sako K; Tanaka S
    Pathol Int; 2022 Nov; 72(11):558-565. PubMed ID: 36200664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular defects in Krabbe disease.
    Tatsumi N; Inui K; Sakai N; Fukushima H; Nishimoto J; Yanagihara I; Nishigaki T; Tsukamoto H; Fu L; Taniike M
    Hum Mol Genet; 1995 Oct; 4(10):1865-8. PubMed ID: 8595408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound Galactosylceramidase Gene (GALC) Heterozygosity in a Boy with Infantile Krabbe Disease (KD).
    Gucev Z; Tasic V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(3):99-101. PubMed ID: 27442402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation.
    Fiumara A; Barone R; Arena A; Filocamo M; Lissens W; Pavone L; Sorge G
    Clin Genet; 2011 Nov; 80(5):452-8. PubMed ID: 21070211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular findings in 6 Turkish cases with Krabbe disease.
    Aslanger AD; Şengenç E; Kölemen AB; Demiral E; Alkan A; İşcan A; Yeşil G
    Turk J Pediatr; 2022; 64(1):69-78. PubMed ID: 35286032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.